[Efficacy and safety of BTK inhibitor combined with bendamustine and rituximab in the first-line treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma].

S C Qin, R Jiang,Y Q Sha, J Y Qiu, H L Mi, Y Miao,W Wu,L Wang, L Fan, W Xu,J Y Li,H Y Zhu

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi(2023)

引用 0|浏览4
暂无评分
关键词
btk inhibitor,chronic lymphocytic leukemia/small,leukemia/small lymphocytic lymphoma,first-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要